Fundraising September 15, 2024 – October 1, 2024 About fundraising

Cost-effectiveness of ceritinib in previously untreated...

  • Main
  • 2018 / 02
  • Cost-effectiveness of ceritinib in previously untreated...

Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States

Zhou, Zheng-Yi, Mutebi, Alex, Han, Simeng, Bensimon, Arielle G., Ricculli, Marie Louise, Xie, Jipan, Dalal, Anand, Culver, Ken
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2018.1443111
Date:
February, 2018
File:
PDF, 1.75 MB
english, 2018
Conversion to is in progress
Conversion to is failed